
- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
別名: MK5172 中文名稱:格佐匹韋,格拉瑞韋
Grazoprevir anhydrous (MK5172) 是一種 Hepatitis C Virus NS3/4A Protease 的抑制劑,HCV genotype 1a、1B和4的IC50值分別為7pM、4pM和62pM。
Grazoprevir Chemical Structure
CAS: 1350514-68-9
| 相關產(chǎn)品 | Danoprevir Lomibuvir (VX-222) Asunaprevir PSI-6206 (GS-331007) | 點擊展開 |
|---|---|---|
| 相關化合物庫 | FDA藥物庫 天然產(chǎn)物庫 已知活性藥物庫-I 蛋白酶抑制劑庫 泛素化化合物庫 | 點擊展開 |
| 細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息(PMID) |
|---|---|---|---|---|---|
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against HCV genotype 1a infected in human HuH7 cells assessed as inhibition of viral replication after 72 hrs by RT-PCR method, EC50=0.0003μM. | 26819676 | |
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against HCV genotype 1b infected in human HuH7 cells assessed as inhibition of viral replication after 72 hrs by RT-PCR method, EC50=0.0003μM. | 26819676 | |
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against HCV genotype 1a infected in human HuH7 cells assessed as reduction viral RNA level after 72 hrs by RT-PCR method, EC50=0.0006μM. | 27994759 | |
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against HCV genotype 1b infected in human HuH7 cells assessed as reduction viral RNA level after 72 hrs by RT-PCR method, EC50=0.0006μM. | 27994759 | |
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against HCV genotype 2a infected in human HuH7 cells assessed as inhibition of viral replication after 72 hrs by RT-PCR method, EC50=0.0012μM. | 26819676 | |
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against Hepatitis C virus genotype 1b infected in HuH7 cells assessed as reduction in replicon RNA level after 72 hrs by TaqMan-based RT-PCR analysis in presence of 10% FBS, EC50=0.0015μM. | 24900818 | |
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against HCV genotype 2b infected in human HuH7 cells assessed as inhibition of viral replication after 72 hrs by RT-PCR method, EC50=0.005μM. | 26819676 | |
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against HCV genotype 2a infected in human HuH7 cells assessed as reduction viral RNA level after 72 hrs by RT-PCR method, EC50=0.0054μM. | 27994759 | |
| HuH7 | Antiviral assay | 24 hrs | Antiviral activity against Hepatitis C virus genotype 1a infected in human HuH7 cells assessed as inhibition of viral replication after 24 hrs presence of 40% NHS, IC50=0.007μM. | 24900473 | |
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against HCV genotype 3a infected in human HuH7 cells assessed as inhibition of viral replication after 72 hrs by RT-PCR method, EC50=0.0072μM. | 26819676 | |
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against HCV genotype 3a infected in human HuH7 cells assessed as reduction viral RNA level after 72 hrs by RT-PCR method, EC50=0.0072μM. | 27994759 | |
| HuH7 | Antiviral assay | 24 hrs | Antiviral activity against Hepatitis C virus (isolate Con1) genotype 1b infected in human HuH7 cells assessed as inhibition of viral replication after 24 hrs in presence of 50% NHS, IC50=0.0074μM. | 24900473 | |
| HuH7 | Antiviral assay | 72 hrs | Antiviral activity against Hepatitis C virus genotype 3a infected in HuH7 cells assessed as reduction in replicon RNA level after 72 hrs by TaqMan-based RT-PCR analysis in presence of 10% FBS, EC50=0.013μM. | 24900818 | |
| HBI10A | Antiviral assay | Antiviral activity against Hepatitis C virus subtype 1b infected in HBI10A cells harboring HCV subgenomic bicistronic replicon assessed as reduction in viral replication, EC50=0.002μM. | ChEMBL | ||
|
點擊查看更多細胞系數(shù)據(jù) |
|||||
| 產(chǎn)品描述 | Grazoprevir anhydrous (MK5172) 是一種 Hepatitis C Virus NS3/4A Protease 的抑制劑,HCV genotype 1a、1B和4的IC50值分別為7pM、4pM和62pM。 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 靶點 |
|
|
|
|||||
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT03105349 | Withdrawn | HCV |
Fundacion SEIMC-GESIDA |
July 1 2017 | Phase 4 |
| NCT03145623 | Completed | Hepatitis C|Chronic Kidney Diseases |
University Hospital Toulouse|MSD France |
June 2 2017 | -- |
| NCT02973503 | Completed | Chronic HCV Infection |
University Hospital Clermont-Ferrand|Merck Sharp & Dohme LLC |
January 11 2017 | Phase 3 |
|
| 分子量 | 766.9 | 分子式 | C38H50N6O9S |
| CAS號 | 1350514-68-9 | SDF | Download Grazoprevir SDF |
| Smiles | CC(C)(C)C1C(=O)N2CC(CC2C(=O)NC3(CC3C=C)C(=O)NS(=O)(=O)C4CC4)OC5=NC6=C(C=CC(=C6)OC)N=C5CCCCCC7CC7OC(=O)N1 | ||
| 儲存條件(自收到貨起) | |||
|
體外溶解度 |
DMSO : 100 mg/mL ( (130.39 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Ethanol : 100 mg/mL (130.39 mM) Water : Insoluble |
|
|
體內(nèi)溶解配方 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
|
|||||
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內(nèi)配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結(jié)果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內(nèi)配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內(nèi)配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內(nèi)盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項